AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
AMOXICILLIN BP
15 registrations across 3 African markets— 2 active
Markets with AMOXICILLIN BP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Amoxer oral suspension Suspension for Oral Use | 🇿🇲Zambia | INTERMAC LIMITED | active | Jul 2030 |
| Amoxi-denk 500 tablets Tablet Uncoated | 🇿🇲Zambia | Denk Pharma GmbH & Co. KG | active | Jul 2030 |
| MEDOMOX 125MG/5ML SUSPENSION SUSPENSION | 🇲🇼Malawi | — | expired | Mar 2025 |
| MEDOMOX* 250MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Jun 2023 |
| AMCLAVIN 156.25 POWDER FOR ORAL SUSPENSION SUSPENSION 1X100ML | 🇳🇬Nigeria | SEAGREEN PHARMA LTD 3 | expired | Oct 2021 |
| ASMOX 250MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Jun 2017 |
| MILOXY 125MG/5ML GRANULES FOR SUSPENSION GRANULES FOR SUSPENSION | 🇲🇼Malawi | — | expired | Jun 2014 |
| MILOXY 250MG CAPSULES CAPSULES | 🇲🇼Malawi | — | expired | Jun 2014 |
| AMOXICILLIN_ 125MG/5ML ORAL SUSPENSION ORAL SUSPENSION | 🇲🇼Malawi | — | expired | Jun 2013 |
| AMOXICILLIN 250MG CAPSULES CAPSULES | 🇲🇼Malawi | — | expired | Jun 2010 |
| NORMOXIL 125MG/5ML POWDER FOR SUSPENSION POWDER FOR SUSPENSION | 🇲🇼Malawi | — | expired | Jun 2009 |
| NORMOXIL 500MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Jun 2009 |
| APMOX-250 250MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Jun 2005 |
| MOXMAR 250MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Jun 2005 |
| MOXMAR-500 500MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Jun 2005 |
AMOXICILLIN BP in Africa — Regulatory Overview
AMOXICILLIN BP is registered across 3 African markets with 15 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Zambia, Nigeria. AfricaRegulatory refreshes this data daily from official government sources.
Of the 15 registrations, 2 (13%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.